Works matching AU Dutta, Sandeep

Results: 78

Shifting from the Status Quo: A Conceptual Framework to Enhance the Field of Sport for Development Integrating the Capabilities Approach and Critical Pedagogy.

Published in:

Youth (2673-995X), 2025, v. 5, n. 2, p. 35, doi. 10.3390/youth5020035

By:

Dutta, Sandeep;
Evanovich, Justin;
Klein, Max

Publication type:

Article

Multiple dose pharmacokinetics of fiduxosin under fasting conditions in healthy elderly male subjects.

Published in:

Journal of Pharmacy & Pharmacology, 2002, v. 54, n. 5, p. 641, doi. 10.1211/0022357021778952

By:

Dutta, Sandeep;
Zhang, Yiming;
Daszkowski, Daniel J.;
Granneman, G. Richard;
Verlinden, Marleen

Publication type:

Article

Organizational Capacity and Implicit Bias in Experiential Learning.

Published in:

Case Studies Sport Management (2167-2458), 2024, v. 13, n. 1, p. 32, doi. 10.1123/cssm.2023-0041

By:

Ebron, Kolin;
Alonso Restrepo, Julián;
Morales Jr., A. Jaime;
Dutta, Sandeep;
McGarry, Jennifer E.

Publication type:

Article

Impact of a High‐Fat Meal on the Pharmacokinetics of Sotorasib, a KRAS G12C Inhibitor.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 11, p. 1219, doi. 10.1002/cpdd.1452

By:

Cardona, Panli;
Dutta, Sandeep;
Houk, Brett

Publication type:

Article

Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of Sotorasib.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 810, doi. 10.1002/cpdd.1392

By:

Cardona, Panli;
Dutta, Sandeep;
Houk, Brett

Publication type:

Article

Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 3, p. 388, doi. 10.1002/cpdd.1028

By:

Trivedi, Ashit;
Sohn, Winnie;
Hsu, Cheng‐Pang;
Jafarinasabian, Pegah;
Zhang, Hanze;
Hutton, Shauna;
Flach, Stephen;
Abbasi, Siddique;
Dutta, Sandeep;
Lee, Edward

Publication type:

Article

Pharmacokinetic Evaluation of the CYP3A4 and CYP2D6 Drug‐Drug Interaction and CYP3A4 Induction Potential of Omecamtiv Mecarbil: Two Open‐Label Studies in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 185, doi. 10.1002/cpdd.987

By:

Trivedi, Ashit;
Malik, Fady I.;
Jafarinasabian, Pegah;
Zhang, Hanze;
Flach, Stephen;
Abbasi, Siddique;
Dutta, Sandeep;
Lee, Edward

Publication type:

Article

Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 1, p. 129, doi. 10.1002/cpdd.997

By:

Trivedi, Ashit;
Sohn, Winnie;
Jafarinasabian, Pegah;
Zhang, Hanze;
Terminello, Bianca;
Flach, Stephen;
Abbasi, Siddique;
Dutta, Sandeep;
Lee, Edward

Publication type:

Article

Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1442, doi. 10.1002/cpdd.969

By:

Trivedi, Ashit;
Oberoi, Rajneet K.;
Mackowski, Mia;
Jafarinasabian, Pegah;
Zhang, Hanze;
Flach, Stephen;
Hutton, Shauna;
Abbasi, Siddique;
Dutta, Sandeep;
Lee, Edward

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability Following Single and Multiple Doses of Pibrentasvir in a First-in-Human Study.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 44, doi. 10.1002/cpdd.350

By:

Lin, Chih‐Wei;
Dutta, Sandeep;
Asatryan, Armen;
Wang, Haoyu;
Clifton, II, Jack;
Campbell, Andrew;
Liu, Wei

Publication type:

Article

Drug-Drug Interaction of Omeprazole With the HCV Direct-Acting Antiviral Agents Paritaprevir/Ritonavir and Ombitasvir With and Without Dasabuvir.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 269, doi. 10.1002/cpdd.246

By:

Polepally, Akshanth R.;
Dutta, Sandeep;
Hu, Beibei;
Podsadecki, Thomas J.;
Awni, Walid M.;
Menon, Rajeev M.

Publication type:

Article

Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2006, v. 31, n. 4, p. 321, doi. 10.1111/j.1365-2710.2006.00739.x

By:

Dutta, Sandeep;
Reed, R. C.

Publication type:

Article

Panitumumab: A Review of Clinical Pharmacokinetic and Pharmacology Properties After Over a Decade of Experience in Patients with Solid Tumors.

Published in:

Advances in Therapy, 2021, v. 38, n. 7, p. 3712, doi. 10.1007/s12325-021-01809-4

By:

Kast, Johannes;
Dutta, Sandeep;
Upreti, Vijay V.

Publication type:

Article

Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA‐Based Therapeutics Using a Mechanistic Physiologically‐Based Pharmacokinetic‐Pharmacodynamic Model.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1054, doi. 10.1002/cpt.3160

By:

Lumen, Annie;
Zhang, Xinwen;
Dutta, Sandeep;
Upreti, Vijay V.

Publication type:

Article

A Mechanistic Physiologically‐Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell Engagers.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 457, doi. 10.1002/cpt.3056

By:

Zhang, Xinwen;
Lumen, Annie;
Wong, Hansen;
Connarn, Jamie;
Dutta, Sandeep;
Upreti, Vijay V.

Publication type:

Article

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Properties of Rozibafusp Alfa, a Bispecific Inhibitor of BAFF and ICOSL: Analyses of Phase I Clinical Trials.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 371, doi. 10.1002/cpt.2929

By:

Abuqayyas, Lubna;
Chen, Po‐Wei;
dos Santos, Marcia Teixeira;
Parnes, Jane R.;
Doshi, Sameer;
Dutta, Sandeep;
Houk, Brett E.

Publication type:

Article

The impact of hepatic and renal function on panitumumab exposures in patients with metastatic RAS wild-type colorectal cancer.

Published in:

2021

By:

Liao, Michael Z.;
Prenen, Hans;
Dutta, Sandeep;
Upreti, Vijay V.

Publication type:

journal article

Functional Half-Life is a Meaningful Descriptor of Steady-State Pharmacokinetics of an Extended-Release Formulation of a Rapidly Cleared Drug: As Shown by Once-Daily Divalproex-ER

Published in:

Clinical Drug Investigation, 2006, v. 26, n. 12, p. 681, doi. 10.2165/00044011-200626120-00002

By:

Dutta, Sandeep;
Reed, Ronald C.

Publication type:

Article

What Is the Best Strategy for Converting from Twice-Daily Divalproex to a Once-Daily Divalproex ER Regimen?

Published in:

Clinical Drug Investigation, 2004, v. 24, n. 9, p. 509, doi. 10.2165/00044011-200424090-00002

By:

Reed, Ronald C.;
Dutta, Sandeep

Publication type:

Article

Divalproex to Divalproex Extended Release Conversion.

Published in:

Clinical Drug Investigation, 2004, v. 24, n. 9, p. 495, doi. 10.2165/00044011-200424090-00001

By:

Dutta, Sandeep;
Reed, Ronald C.

Publication type:

Article

Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic Drugs.

Published in:

Clinical Drug Investigation, 2003, v. 23, n. 10, p. 661, doi. 10.2165/00044011-200323100-00005

By:

Sommerville, Kenneth W.;
Sandeep Dutta, Kenneth W.;
Bilton, Victor;
Yiming Zhang;
Cloyd, James C.;
Basim Uthman, James C.

Publication type:

Article

Estimation of time to progression and post progression survival using joint modeling of summary level OS and PFS data with an ordinary differential equation model.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2022, v. 49, n. 4, p. 455, doi. 10.1007/s10928-022-09816-w

By:

Nagase, Mario;
Doshi, Sameer;
Dutta, Sandeep;
Lin, Chih-Wei

Publication type:

Article

Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 187, doi. 10.1111/bcp.14939

By:

Trivedi, Ashit;
Hsu, Cheng‐Pang;
Jafarinasabian, Pegah;
Terminello, Bianca;
Zhang, Hanze;
Flach, Stephen;
Israel, Samuel;
Brooks, Ashley;
Xue, Hongqi;
Darpo, Borje;
Abbasi, Siddique;
Dutta, Sandeep;
Lee, Edward

Publication type:

Article

Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 3, p. 527, doi. 10.1111/bcp.13138

By:

Mensing, Sven;
Eckert, Doerthe;
Sharma, Shringi;
Polepally, Akshanth R.;
Khatri, Amit;
Podsadecki, Thomas J.;
Awni, Walid M.;
Menon, Rajeev M.;
Dutta, Sandeep

Publication type:

Article

Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets.

Published in:

British Journal of Clinical Pharmacology, 2014, v. 78, n. 1, p. 94, doi. 10.1111/bcp.12324

By:

Othman, Ahmed A.;
Dutta, Sandeep

Publication type:

Article

The H<sub>3</sub> antagonist ABT-288 is tolerated at significantly higher exposures in subjects with schizophrenia than in healthy volunteers.

Published in:

British Journal of Clinical Pharmacology, 2014, v. 77, n. 6, p. 965, doi. 10.1111/bcp.12281

By:

Othman, Ahmed A.;
Haig, George;
Florian, Hana;
Locke, Charles;
Gertsik, Lev;
Dutta, Sandeep

Publication type:

Article

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter].

Published in:

Clinical Pharmacology, 2020, v. 12, p. 189, doi. 10.2147/CPAA.S289793

By:

Liao, Michael Z;
Kast, Johannes;
Berkhout, Marloes;
Prenen, Hans;
Dutta, Sandeep;
Upreti, Vijay V

Publication type:

Article

Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not.

Published in:

Clinical Pharmacology, 2020, v. 12, p. 109, doi. 10.2147/CPAA.S262949

By:

Liao, Michael Z;
Berkhout, Marloes;
Prenen, Hans;
Dutta, Sandeep;
Upreti, Vijay V

Publication type:

Article

Population Pharmacokinetics of Sotorasib in Healthy Subjects and Advanced Solid Tumor Patients Harboring a KRAS<sup>G12C</sup> Mutation from Phase 1 and Phase 2 Studies.

Published in:

AAPS Journal, 2025, v. 27, n. 1, p. 1, doi. 10.1208/s12248-024-01013-6

By:

Nagase, Mario;
Houk, Brett;
Vuu, Irene;
Cardona, Panli;
Dutta, Sandeep;
Lin, Chih-Wei

Publication type:

Article

Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies.

Published in:

AAPS Journal, 2016, v. 18, n. 1, p. 270, doi. 10.1208/s12248-015-9846-1

By:

Mensing, Sven;
Polepally, Akshanth;
König, Denise;
Khatri, Amit;
Liu, Wei;
Podsadecki, Thomas;
Awni, Walid;
Menon, Rajeev;
Dutta, Sandeep

Publication type:

Article

Population Pharmacokinetics and Exposure-Uric Acid Analyses After Single and Multiple Doses of ABT-639, a Calcium Channel Blocker, in Healthy Volunteers.

Published in:

AAPS Journal, 2015, v. 17, n. 2, p. 416, doi. 10.1208/s12248-014-9709-1

By:

An, Guohua;
Liu, Wei;
Duan, W.;
Nothaft, Wolfram;
Awni, Walid;
Dutta, Sandeep

Publication type:

Article

Erratum to: Population Pharmacokinetics and Exposure-Uric Acid Analyses After Single and Multiple Doses of ABT-639, a Calcium Channel Blocker, in Healthy Volunteers.

Published in:

2015

By:

An, Guohua;
Liu, Wei;
Duan, W.;
Nothaft, Wolfram;
Awni, Walid;
Dutta, Sandeep

Publication type:

Erratum

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients.

Published in:

AAPS Journal, 2013, v. 15, n. 2, p. 316, doi. 10.1208/s12248-012-9439-1

By:

Nyholm, Dag;
Odin, Per;
Johansson, Anders;
Chatamra, Krai;
Locke, Charles;
Dutta, Sandeep;
Othman, Ahmed A.

Publication type:

Article

Population Analyses of Efficacy and Safety of ABT-594 in Subjects with Diabetic Peripheral Neuropathic Pain.

Published in:

AAPS Journal, 2012, v. 14, n. 2, p. 168, doi. 10.1208/s12248-012-9328-7

By:

Dutta, Sandeep;
Hosmane, Balakrishna;
Awni, Walid

Publication type:

Article

Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator.

Published in:

Biopharmaceutics & Drug Disposition, 2021, v. 42, n. 7, p. 319, doi. 10.1002/bdd.2293

By:

Trivedi, Ashit;
Oberoi, Rajneet K.;
Mackowski, Mia;
Jafarinasabian, Pegah;
Zhang, Hanze;
Flach, Stephen;
Simiens, Mary Ann;
Terminello, Bianca;
Abbasi, Siddique;
Dutta, Sandeep;
Lee, Edward

Publication type:

Article

Population pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 in healthy volunteers following single and multiple dose regimens.

Published in:

Biopharmaceutics & Drug Disposition, 2014, v. 35, n. 7, p. 417, doi. 10.1002/bdd.1912

By:

An, Guohua;
Liu, Wei;
Katz, David A.;
Marek, Gerard J.;
Awni, Walid;
Dutta, Sandeep

Publication type:

Article

Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436.

Published in:

Psychopharmacology, 2016, v. 233, n. 1, p. 71, doi. 10.1007/s00213-015-4089-5

By:

Katz, David;
Liu, Wei;
Locke, Charles;
Dutta, Sandeep;
Tracy, Katherine

Publication type:

Article

Mechanistic Pharmacokinetic/Pharmacodynamic Modeling in Support of a Patient-Convenient, Longer Dosing Interval for Carfilzomib, a Covalent Inhibitor of the Proteasome.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 5, p. 779, doi. 10.1007/s40262-023-01242-6

By:

Yago, Marc R.;
Mehta, Khamir;
Bose, Maitreyee;
Bhagwat, Sharvari;
Chopra, Vivek S.;
Dutta, Sandeep;
Upreti, Vijay V.

Publication type:

Article

Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil.

Published in:

Clinical Pharmacokinetics, 2021, v. 60, n. 8, p. 1041, doi. 10.1007/s40262-021-01014-0

By:

Trivedi, Ashit;
Oberoi, Rajneet K.;
Jafarinasabian, Pegah;
Zhang, Hanze;
Flach, Stephen;
Abbasi, Siddique;
Dutta, Sandeep;
Lee, Edward

Publication type:

Article

Clinical Pharmacokinetics of Ombitasvir.

Published in:

2017

By:

Badri, Prajakta;
Shuster, Diana;
Dutta, Sandeep;
Menon, Rajeev;
Badri, Prajakta S;
Shuster, Diana L;
Menon, Rajeev M

Publication type:

journal article

Clinical Pharmacokinetics of Dasabuvir.

Published in:

2017

By:

King, Jennifer;
Zha, Jiuhong;
Khatri, Amit;
Dutta, Sandeep;
Menon, Rajeev;
King, Jennifer R;
Menon, Rajeev M

Publication type:

journal article

Clinical Pharmacokinetics of Paritaprevir.

Published in:

2017

By:

Menon, Rajeev;
Polepally, Akshanth;
Khatri, Amit;
Awni, Walid;
Dutta, Sandeep;
Menon, Rajeev M;
Polepally, Akshanth R;
Awni, Walid M

Publication type:

journal article

Pharmacokinetics and Tolerability of Anti-Hepatitis C Virus Treatment with Ombitasvir, Paritaprevir, Ritonavir, with or Without Dasabuvir, in Subjects with Renal Impairment.

Published in:

2017

By:

Khatri, Amit;
Dutta, Sandeep;
Marbury, Thomas;
Preston, Richard;
Rodrigues, Lino;
Wang, Haoyu;
Awni, Walid;
Menon, Rajeev;
Marbury, Thomas C;
Preston, Richard A;
Rodrigues, Lino Jr;
Awni, Walid M;
Menon, Rajeev M

Publication type:

journal article

Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies.

Published in:

2016

By:

Polepally, Akshanth;
Mensing, Sven;
Khatri, Amit;
Beck, Denise;
Liu, Wei;
Awni, Walid;
Menon, Rajeev;
Dutta, Sandeep;
Polepally, Akshanth R;
Awni, Walid M;
Menon, Rajeev M

Publication type:

journal article

Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy.

Published in:

2016

By:

Badri, Prajakta;
King, Jennifer;
Polepally, Akshanth;
McGovern, Barbara;
Dutta, Sandeep;
Menon, Rajeev;
Badri, Prajakta S;
King, Jennifer R;
Polepally, Akshanth R;
McGovern, Barbara H;
Menon, Rajeev M

Publication type:

journal article

Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel Versus Oral Administration of Levodopa-Carbidopa Tablets in Japanese Subjects with Advanced Parkinson's Disease: Pharmacokinetics and Pilot Efficacy and Safety.

Published in:

Clinical Pharmacokinetics, 2015, v. 54, n. 9, p. 975, doi. 10.1007/s40262-015-0265-3

By:

Othman, Ahmed;
Chatamra, Krai;
Mohamed, Mohamed-Eslam;
Dutta, Sandeep;
Benesh, Janet;
Yanagawa, Masayoshi;
Nagai, Masahiro

Publication type:

Article

Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers: Integrated Analysis of Intravenous and Subcutaneous, Single- and Multiple-Dose Administration.

Published in:

Clinical Pharmacokinetics, 2014, v. 53, n. 10, p. 907, doi. 10.1007/s40262-014-0159-9

By:

Othman, Ahmed;
Tran, Jonathan;
Tang, Meina;
Dutta, Sandeep

Publication type:

Article

Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors.

Published in:

Clinical Infectious Diseases, 2016, v. 62, n. 8, p. 972, doi. 10.1093/cid/civ1213

By:

Khatri, Amit;
Dutta, Sandeep;
Haoyu Wang;
Podsadecki, Thomas;
Trinh, Roger;
Awni, Walid;
Menon, Rajeev

Publication type:

Article

Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development.

Published in:

CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2057, doi. 10.1111/cts.13349

By:

Kast, Johannes;
Nozohouri, Saeideh;
Zhou, Di;
Yago, Marc R.;
Chen, Po‐Wei;
Ahamadi, Malidi;
Dutta, Sandeep;
Upreti, Vijay V.

Publication type:

Article

Evaluation of drug‐drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically‐based pharmacokinetic model.

Published in:

CTS: Clinical & Translational Science, 2021, v. 14, n. 6, p. 2510, doi. 10.1111/cts.13118

By:

Trivedi, Ashit;
Sohn, Winnie;
Kulkarni, Priyanka;
Jafarinasabian, Pegah;
Zhang, Hanze;
Spring, Marintan;
Flach, Stephen;
Abbasi, Siddique;
Wahlstrom, Jan;
Lee, Edward;
Dutta, Sandeep

Publication type:

Article